New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Merck & ...

Located at Chestnut Run Innovation & Science Park, the Merck Wilmington Biotech project will comprise laboratory, ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future medicines to market.

We recently published a list of 10 Jim Cramer Stocks to Watch Amid Trump Tariff Wars. In this article, we are going to take a ...

2025--Merck Breaks Ground on New $1 billion Biologics Center of Excellence in Wilmington, Delaware Merck (NYSE:MRK) recently announced promising results from its Phase 3 KEYNOTE-689 trial of ...

US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted ...

A study of 24,000 breast cancer survivors in Japan showed the women had significantly higher risk of non-cancer diseases -- ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...